Stay updated on Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe footer revision label has been updated from v3.5.2 to v3.5.3, indicating a site/version release without changing the study details presented on the page.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3. This is a metadata revision and does not affect the study information.SummaryDifference0.1%

- Check88 days agoChange DetectedAdded Revision: v3.4.2. Removed the Revision: v3.4.1 notice regarding government funding status.SummaryDifference0.4%

- Check95 days agoChange DetectedAdded a site-wide notice about government funding and operating status, and updated the page revision information to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page.